The Latest Breaking News from Nasdaq

Tesla (NASDAQ:TSLA) has outperformed the market over the past 10 years by 47.64% on an annualized basis producing an average annual return of 59.02%. Currently, Tesla has a market capitalization of $679.55 billion.

According to Benzinga Pro, during Q1, Sovos Brands (NASDAQ:SOVO) earned $4.06 million, a 205.65% increase from the preceding quarter. Sovos Brands also posted a total of $209.93 million in sales, a 10.93% increase since Q4.

Starbucks Corp (NASDAQ:SBUX) is shutting down its business in Russia, the Wall Street Journal reported. The coffee giant has decided to permanently close operations in its 130 stores and would no longer have an operation in Russia. The company had suspended its licensee's Russian business on March 8. The report noted the company…

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) has acquired Satiogen Pharmaceuticals Inc in a cash and stock deal. The deal consideration includes 841,792 shares, 199,993 of which are subject to the achievement of a milestone, and approximately $2.8 million in cash.  Mirum will wholly own the Satiogen subsidiary, which will receive a 2% royalty. Satiogen was an…

Cal Microturbine, Capstone Green Energy Corp's (NASDAQ:CGRN) exclusive distributor for California, Hawaii, Nevada, Oregon, and Washington, has secured six orders for C65 microturbines throughout the state of California. Financial terms were not disclosed. The 16 C65 units will be installed for customers in the agriculture, oil and gas, and hospitality industries. The systems are…

Innoviva Inc (NASDAQ:INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) at $2.20 per share in cash.  Innoviva currently owns approximately 60% of the outstanding shares of Entasis common stock. The acquisition consideration values Entasis' equity at $113 million on a fully diluted basis. "This acquisition will build upon our overall strategy to acquire differentiated,…

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue…